Literature DB >> 19320749

The role of selective angiographic embolization of the musculo-skeletal system in haemophilia.

E C Rodriguez-Merchan1, V Jimenez-Yuste.   

Abstract

The incidence of haemarthrosis as a result of a spontaneous periarticular aneurysm in haemophilia is very low. In these circumstances, angiographic embolization might be considered as a promising therapeutic and coagulation factor saving option in joint bleeds not responding to replacement of coagulation factor to normal levels. Moreover, embolization should be considered as a possible treatment for postoperative pseudoaneurysms complicating total knee arthroplasty in haemophilia. However, the pathological process of aneurysmal bleeding and clotting factor replacement is entirely different. While embolization is the treatment of choice for some periarticular complications that may occur, it is by no means a panacea for all resistant periarticular bleeds in haemophilia or for postoperative bleeding which usually settles with clotting factor replacement. Another use of arterial embolization is for the treatment of haemophilic tumours of the pelvis, because they can act as a focus for infection and cause cutaneous fistulas. When they present perforations and infections of endogenous origin, their course is usually fatal. Suitable treatment has been investigated on numerous occasions, most of the literature agreeing that the only curative treatment is surgical resection. However, surgical resection after performing arterial embolization to reduce the vascularization of the pseudotumour is a good alternative, thereby reducing the size of the pseudotumour and the risk of bleeding complications during surgery. It is important to bear in mind that despite its efficacy, arterial embolization is an invasive procedure with a reported rate of complications up to 25% (16% minor, 7% serious, 2% death).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19320749     DOI: 10.1111/j.1365-2516.2009.02015.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  4 in total

1.  Tailoring care to haemophilia patients' needs: which specialty and when?

Authors:  Massimo Morfini; Gary Benson; Victor Jiménez-Yuste; Rolf Ljung; Pier Mannuccio Mannucci; Gianluigi Pasta; Eduardo Remor; Silva Zupančić Šalek
Journal:  Blood Transfus       Date:  2015-05-20       Impact factor: 3.443

Review 2.  Hemophilic Pseudotumors: Diagnosis and Management.

Authors:  E Carlos Rodriguez-Merchan
Journal:  Arch Bone Jt Surg       Date:  2020-03

Review 3.  Optimal management of hemophilic arthropathy and hematomas.

Authors:  Sébastien Lobet; Cedric Hermans; Catherine Lambert
Journal:  J Blood Med       Date:  2014-10-17

4.  Management of the hemophilic pseudotumor of the abdomen: A rare pathological entity.

Authors:  Javier López-Gómez; Juan S Contreras; Marco Figueroa-Ruiz; Erick Servín-Torres; José Velázquez-García; Francisco Bevia-Pérez; Germán Delgadillo-Teyer
Journal:  Int J Surg Case Rep       Date:  2014-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.